Will Retatrutide (new obesity drug) be FDA approved by the end of 2024?
Mini
6
Ṁ456Jan 1
4%
chance
1D
1W
1M
ALL
Get Ṁ1,000 play money
Sort by:
Phase 3 trial is estimated to complete in late 2025: https://classic.clinicaltrials.gov/ct2/show/NCT05882045
Related questions
Related questions
Will Retatrutide (new obesity drug) be FDA approved by the end of 2025?
46% chance
Will Retatrutide (new obesity drug) be FDA approved by the end of 2026?
85% chance
Will AOH1996 be FDA approved before 2040?
44% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will an AI-designed drug get FDA approval by the end of 2025?
30% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
66% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
43% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
75% chance